HeartSciences Inc.
HSCS · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Market Cap | $3,293 | $3,257 | $6,719 | $5,642 |
| - Cash | $1,098 | $5,808 | $1,660 | $918 |
| + Debt | $2,985 | $1,036 | $1,566 | $6,163 |
| Enterprise Value | $5,180 | -$1,514 | $6,624 | $10,887 |
| Revenue | $4 | $19 | $5 | $14 |
| % Growth | -76.6% | 261.2% | -64.2% | – |
| Gross Profit | $2 | $13 | $2 | $6 |
| % Margin | 56.8% | 67.3% | 45.7% | 45.1% |
| EBITDA | -$8,137 | -$6,156 | -$6,084 | -$4,430 |
| % Margin | -187,053.3% | -33,096.7% | -118,139.8% | -30,822.2% |
| Net Income | -$8,765 | -$6,605 | -$490,854 | -$4,578 |
| % Margin | -201,499.5% | -35,511.9% | -9,531,151.3% | -31,851.8% |
| EPS Diluted | -9.34 | -18.74 | -6,173.88 | -137.94 |
| % Growth | 50.2% | 99.7% | -4,375.8% | – |
| Operating Cash Flow | -$7,413 | -$6,070 | -$5,774 | -$3,644 |
| Capital Expenditures | -$30 | -$125 | -$18 | -$2 |
| Free Cash Flow | -$7,443 | -$6,195 | -$5,792 | -$3,646 |